How do you choose the best treatment options for YOUR multiple myeloma (MM)? With more multiple myeloma treatments being approved and personalized for myeloma patients, Drs. Gareth Morgan, Faith Davies and Frits van Rhee, from the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute, discuss the expanding armamentarium. Dr. Morgan reviews immunomodulatory therapies (IMIDs), checkpoint inhibitors and the continued role of chemotherapy. Dr. Davies focuses on proteasome inhibitors, while Dr. van Rhee explains monoclonal antibodies and antibody conjugates.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo